Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 1143-1147

  Nowak, Gabriel ^a,b   Siwek, Marcin ^b   Dudek, Dominika ^b   Zieba, Andrzej ^b   Pilc, Andrzej ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antidepressant treatment; Placebo; Supplementation; Unipolar depression; Zinc

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; GLUTAMIC ACID; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZINC; ZINC ION; ZINCAS FORTE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; FEMALE; HAMILTON SCALE; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; MAJOR DEPRESSION; MALE; MENTAL HEALTH; MOOD DISORDER; PATIENT SELECTION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STANDARD; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; CITALOPRAM; CLOMIPRAMINE; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; ZINC;

EID: 1642503034     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J.: An inventory for measuring depression. Arch. Gen. Psychiat., 1961, 4, 561-571.
2. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., Krystal J.H.: Antidepressant effects of ketamine in depressed patients. Biol. Psychiat., 2000, 47, 351-354.
3. 3 receptors in peripheral blood lymphocytes of the patients with drug-resistant unipolar depression. Pol. J. Pharmacol., 2002, 54, 703-706.
4. Hamilton M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiat., 1960, 23, 56-61.
5. Kroczka B., Brański P., Pałucha A., Pilc A., Nowak G.: Antidepressant-like properties of zinc in rodent forced swim test. Brain Res. Bull., 2001, 55, 297-300.
6. Kroczka B., Zieba A., Dudek D., Pilc A., Nowak G.: Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol. J. Pharmacol., 2000, 52, 403-406.
7. Maes M., De Vos N., Demedts P., Wauters A., Neels H.: Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J. Affect. Disorders, 1999, 56, 189-194.
8. Maes M., D'Haese P.C., Scharpe S., D'Hondt P.D., Cosyns P., De Broe M.E.: Hipozincemia in depression. J. Affect. Disorders, 1994, 31, 135-140.
9. Maes M., Vandoolaeghe E., Neels H., Demedts P., Wauters A., Meltzer H.Y., Altamura C., Desnyder R.: Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol. Psychiat., 1997, 42, 349-358.
10. McLoughlin I.J., Hodge J.S.: Zinc in depressive disorder. Acta Psychiat. Scand., 1990, 82, 451-453.
11. Nowak G., Kubera M., Maes M.: Neuroimmunological aspects of the alterations in zinc homeostasis in the pathophysiology and treatment of depression. Acta Neuropsychiat., 2000, 12, 49-53.
12. Nowak G., Schlegel-Zawadzka M.: Alterations in serum and brain trace element levels after antidepressant treatment. Part I. Zinc. Biol. Tr. Elem. Res., 1999, 67, 85-92.
13. Nowak G., Szewczyk B.: Mechanism contributing to antidepressant zinc actions. Pol. J. Pharmacol., 2002, 54, 587-592.
14. Nowak G., Szewczyk B., Wierońska J.M., Brański P., Pałucha A., Pilc A., Sadlik K., Piekoszewski W.: Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res. Bull., 2003, 61, 159-164.
15. Nowak G., Zieba A., Dudek D., Krośniak M., Szymaczek M., Schlegel-Zawadzka M.: Serum trace elements in animal models and human depression. Part I. Zinc. Hum. Psychopharmacol. Clin. Exp., 1999, 14, 83-86.
16. Ossowska G., Klenk-Majewska B., Danilczuk Z., Wróbel A., Zebrowska-Łupina I., Czajkowski L.: Antidepressant-like effect of zinc hydroaspartate in a chronic unpredictable stress model of depression. In: Molecular and Physiological Aspects of Regulatory Processes of the Organism. Ed. Lach H., Wyd. Nauk. AP, Kraków, 2003, 288-289.
17. Pilc A., Kłodzińska A., Nowak G.: A role for glutamate in the treatment of anxiety and depression: focus on group I metabotropic glutamate (mGlu) receptors. Drugs Fut., 2002, 27, 753-763.
18. Schlegel-Zawadzka M., Zieba A., Dudek D., Krośniak M., Szymaczek M., Nowak G.: Effect of depression and of antidepressant therapy on serum zinc levels - a preliminary clinical study. In: Trace Elements in Man and Animals 10. Kluwer Academic Plenum Press, 2000, 607-610.
19. Skolnick P., Legutko B., Xia L., Bymaster F.P.: Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol. Res., 2001, 43, 411-423.
20. Stryjer R., Strous R.D., Shaked G., Bar F., Feldman B., Kotler M., Polak L., Rosenzcwaig S., Weizman A.: Amantadine as augmentation therapy in the management of treatment-resistant depression. Int. Clin. Psychopharmacol. 2003, 8, 93-96.
21. Szewczyk B., Brański P., Wierońska J.M., Pałucha A., Pilc A., Nowak G.: Interaction of zinc with antidepressants in the forced swimming test in mice. Pol. J. Pharmacol., 2002, 54, 681-685.
22. Vaidya V.A., Siuciak J.A., Du F., Duman R.S.: Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizure. Neuroscience, 1999, 89, 157-166.